HemiPhon Competitors

SomnoMed® leads the world in the development of medical devices for the treatment of mild-to-moderate Obstructive Sleep Apnea, and has innovated OSA treatment options since 2004. Each custom-made oral appliance is designed with patient comfort and therapy effectiveness as the priority, and we strive with the dental and healthcare communities to support 100% therapy compliance in OSA treatment. Learn more at https://somnomed.com/en/ or call 888-447-6673.

Sleep apnea, meet your match. At cpap.com, we demystify sleep apnea and guide you back into the vibrant world of good sleep. As your CPAP-positive partner, we offer expert guidance, top-rated products, and personalized solutions. Family-owned since 1999, we've helped 2 million+ people breathe easier. Let's tackle sleep apnea together and rediscover the power of vibrant, restful nights.

ProSomnus® is the pioneer and global leader in Smart Sleep Medicine™, delivering precision, non-CPAP Oral Appliance Therapy (OAT) for Obstructive Sleep Apnea (OSA), with integrated multi-night physiologic monitoring enabled by its RPMO2 platform. A serious medical disease affecting over 1 billion people worldwide, OSA is linked to life-threatening comorbidities including heart failure, stroke, and type 2 diabetes. By integrating precision-engineered intraoral medical devices with advanced Remote Patient Monitoring (RPM) and data-driven diagnostics, ProSomnus is redefining the standard of care. Our platform is designed to provide continuous, nightly clinical insights that ensure superior adherence and validated patient outcomes. Non-invasive and patient-preferred, ProSomnus devices have demonstrated exceptional efficacy and safety across a rigorous and growing body of clinical evidence. ProSomnus precision devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, and TRICARE, representing over 200 million covered lives globally. To learn more or find a provider near you, visit www.ProSomnus.com.